Back to top

TVTX Maintained by Guggenheim -- Price Target Raised to $65

TVTX Maintained by Guggenheim -- Price Target Raised to $65

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Travere Therapeutics, Inc. (TVTX)